Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer: A plain language summary of the DESTINY-Breast04 study Review
| Author: | Modi, S. |
| Review Title: | Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer: A plain language summary of the DESTINY-Breast04 study |
| Keywords: | adult; cancer chemotherapy; aged; major clinical study; cancer patient; breast cancer; nausea; epidermal growth factor receptor 2; steroid; pneumonia; hospital care; immune response; health care personnel; caregiver; interstitial lung disease; pathological complete response; advanced breast cancer; human; female; article; trastuzumab deruxtecan; plain language |
| Journal Title: | Future Oncology |
| Volume: | 21 |
| Issue: | 4 |
| ISSN: | 1479-6694 |
| Publisher: | Future Medicine |
| Date Published: | 2025-01-01 |
| Start Page: | 367 |
| End Page: | 380 |
| Language: | English |
| DOI: | 10.1080/14796694.2024.2434388 |
| PUBMED: | 39780697 |
| PROVIDER: | scopus |
| PMCID: | PMC11813202 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
